arrow
M

María Luiza de Souza-Galvão

instituto de salud carlos iii
H指数:24
被引数:1,852

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A longitudinal prospective study of active tuberculosis in a Western Europe setting: insights and findings

西欧地区活动性结核病的纵向前瞻性研究: 见解和发现

2024-02-131
OAAI
Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort
2023-10-129
OAAI
Study of the Diagnostic Delay of Tuberculosis in Spain
2021-06-013
PREAI
Discovery and validation of an NMR-based metabolomic profile in urine as TB biomarker
2020-12-1830
OAAI
Diagnostic Accuracy of Interferon Gamma -Induced Protein 10 mRNA Release Assay for Tuberculosis
2020-09-2216
OAAI
Diagnostic benefits of adding EspC, EspF and Rv2348-B to the QuantiFERON Gold In-tube antigen combination
2020-08-064
OAAI
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases
2020-05-26277
OAAI
Cell-Mediated Immune Responses to in vivo-Expressed and Stage-Specific Mycobacterium tuberculosis Antigens in Latent and Active Tuberculosis Across Different Age Groups
2020-02-1129
OAAI
Late Breaking Abstract - Use of non-tuberculous mycobacteria (NTM) specific antigens to detect NTM infection

晚期摘要-使用非结核分枝杆菌 (NTM) 特异性抗原检测NTM感染

2019-11-210
PRE
Study of CD27 and CCR4 Markers on Specific CD4+ T-Cells as Immune Tools for Active and Latent Tuberculosis Management
2019-01-0929
OAAI
Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial

与干扰素 γ 释放试验和结核菌素皮肤试验相比,c-tb皮肤试验诊断结核分枝杆菌感染的安全性和有效性: 一项3期,双盲,随机,对照试验

2017-04-0193
PREAI